Remdesivir is the first drug against COVID-19 to be conditionally approved in Europe and the United States. The drug is designed to suppress the rapid replication of the SARS-CoV-2 virus in human cells by blocking the viral ...
Jan 13, 2021
0
137
In the field of molecular epidemiology, the worldwide scientific community has been sleuthing to solve the riddle of the early history of SARS-CoV-2.
Nov 5, 2020
2
920
Yellow fever virus is normally confined to the Amazon region, but the virus circulated in the Southeast of Brazil between 2016 and 2018, causing the worst epidemic and epizootic outbreaks there for decades. The Ministry of ...
Nov 5, 2020
0
2
A simple COVID-19 test kit combines virus amplification with a CRISPR-Cas system for effective SARS-CoV-2 detection. The kit, called iSCAN, uses reagents that can be locally manufactured.
Nov 5, 2020
0
2
Like a key, SARS-CoV-2—the virus that causes coronavirus disease 2019 (COVID-19) - attaches to specific molecules on the host cell surface, opening gateways into the cell interior. Viral entry into host cells triggers a ...
Oct 29, 2020
0
40
A new study combines evolutionary genomics from coronavirus samples with computer-simulated epidemics and detailed travel records to reconstruct the spread of coronavirus across the world in unprecedented detail.
Sep 10, 2020
0
291
"Know your enemy," Sun Tzu, the great sage of war, wrote some 2,500 years ago. Today, as COVID-19 spreads around the globe, the greatest army of medical scientists ever assembled is bent on learning all it can, as fast as ...
Sep 10, 2020
0
5
A 33-year old man was found to have a second SARS-CoV-2 infection some four and a half months after he was diagnosed with his first, from which he recovered. The man, who showed no symptoms, was diagnosed when he returned ...
Aug 25, 2020
0
5
The Epstein-Barr virus (EBV), one of the most common human viruses, is associated with about 8 to 10% of stomach—or gastric—cancers, the third leading cause of cancer death globally. Researchers from Chiba University ...
Jul 27, 2020
0
301
Researchers at the University of New Hampshire have identified new pathways in an RNA-based virus where inhibitors, like medical treatments, unbind. The finding could be beneficial in understanding how these inhibitors react ...
Jul 22, 2020
0
0
